The 'human topoisomerase I (htopoI) damage response' was reported to be triggered by various kinds of DNA lesions. Also, a high and persistent level of htopoI cleavage complexes correlated with apoptosis. In the present study, we demonstrate that DNA damage-independent induction of cell death using colcemid and tumor necrosis factor a is also accompanied by a strong htopoI response that correlates with the onset of apoptotic hallmarks. Consequently, these results suggest that htopoI cleavage complex formation may be caused by signaling pathways independent of the kind of cellular stress. Thus, protein interactions or signaling cascades induced by DNA damage or cellular stress might lead to the formation of stabilized cleavage complexes rather than the DNA lesion itself. Finally, we show that p53 not only plays a key role in the regulation of the htopoI response to UV-C irradiation but also to treatment with colcemid.
Introduction
The conventional role of human topoisomerase I (htopoI) comprises the relaxation of tension generated during DNA replication or transcription processes. This is achieved by the transient cleavage of one DNA strand. By cutting the DNA, htopoI becomes covalently attached to the 3 0 -end of the scissile strand thereby generating a free 5 0 -OH group. Under normal conditions this covalent intermediate, referred to as 'cleavage complex', is only short lived and is rapidly reversed by subsequent enzyme-mediated religation (reviewed in Champoux (2001) ). For several decades it has been known, that these cleavage complexes can be stabilized by the action of drugs belonging to the camptothecin (CPT) family. CPT, a herbal alkaloid isolated from the chinese tree Camptotheca acuminata, is known to be an inhibitor of htopoI that interferes specifically with the enzyme DNA interface in the cleavage complex (Hsiang et al., 1985) . Derivatives of CPT are used as effective anticancer drugs against a broad spectrum of solid tumors (Li and Liu, 2001) .
A few years ago, it emerged that cells treated with various DNA damaging agents also generate stabilized cleavage complexes. This stabilization was found to be basically due to a slowdown or inhibition of the religation step of htopoI. Since then, the so-called 'htopoI damage response' has been under investigation. It could be shown that the htopoI response is triggered by various kinds of DNA damage, like oxidative lesions induced by hydrogen peroxide (Daroui et al., 2004) , arsenic compounds (Sordet et al., 2004b) , or staurosporine (Sordet et al., 2004a) , bulky adducts caused by, for example, benzo[a]-pyrene , base methylations (Pourquier et al., 2001) , UV lesions (Subramanian et al., 1998; Soe et al., 2004) , or antimetabolite incorporation (Pourquier et al., , 2002 . Although the purpose of cleavage complex formation is still unclear, current data suggest that there might be an involvement in DNA repair (Subramanian et al., 1998; Mao and Muller, 2003) and/or apoptosis (Soe et al., 2004; Sordet et al., 2004a, b) . Downregulation of htopoI by antisense mRNA resulted in a reduced repair capacity of UV-induced DNA lesions, indicating a role in nucleotide excision repair (Mao and Muller, 2003) . On the other hand, the htopoI damage response actively contributes to cell killing, since downregulation of htopoI by siRNA significantly reduced the apoptosis-related DNA fragmentation in response to treatment with arsenic compounds and staurosporine (Sordet et al., 2004a, b) . The important determinant for deciding which role htopoI plays, may be the degree of cellular damage. Low dose irradiation with UV-C light, allowing cellular survival, induced only a weak and transient htopoI damage response. On the other hand, high irradiation doses provoked a very pronounced cleavage complex level that persisted for several hours. This enhanced htopoI response correlated with apoptosis (Soe et al., 2004) . Further evidence for a role of the htopoI response in cell death was obtained by separating apoptotic from vital cells after UV-C irradiation. It could be shown that htopoI cleavage complexes were primarily found in the apoptotic fraction, whereas vital cells displayed a very weak htopoI response (Soe et al., 2004) . Although the regulation of cleavage complex formation is still unclear, it has been suggested that the tumor suppressor p53 is a key factor for the onset of the htopoI damage response (Mao et al., 2000) . Given that p53 is important for the induction of apoptosis following DNA damage it could be a link between the htopoI response and apoptosis.
All studies performed so far have focused on the ability of different kinds of DNA lesions to induce htopoI cleavage complexes. To gain further insight into the mechanism behind the htopoI response, we set out to investigate whether it is also activated when non-DNA damaging agents induce apoptosis. In the present work, we used colcemid, a microtubule inhibitor, as well as tumor necrosis factor a (TNFa), which induces receptor-mediated apoptosis. Colcemid, a pure aneugenic compound, is known to arrest cells in M phase, followed by induction of apoptosis (Sherwood et al., 1994) . Our results show that cells directed to apoptosis by treatment with colcemid possess an elevated level of htopoI cleavage complexes. This cellular response seems to be dependent on p53, at least in the lung carcinoma cell line H1299. Finally, receptor-mediated apoptosis induced by TNFa resulted in a very strong htopoI damage response, further indicating a general involvement of htopoI in apoptosis. In conclusion, our findings suggest that a pronounced htopoI cleavage complex formation is a general feature of cells undergoing apoptosis, independent of the type of the apoptotic stimulus.
Results
A pronounced htopoI response was observed in cells undergoing apoptosis caused by various kinds of DNA lesions (Soe et al., 2004; Sordet et al., 2004a, b) . To examine whether DNA damage-independent induction of apoptosis can also trigger cleavage complex formation, HeLa cells were treated with different concentrations of colcemid for 72 h. Treatment with 1 and 5 ng/ml colcemid displayed no or only modest cytotoxic effects, whereas 10, 50 and 100 ng/ml induced pronounced cell death as measured by flow cytometry analysis ( Figure 1a ). This is particular clear due to the massive appearance of a sub-G1 peak at colcemid concentrations of 10 ng/ml or more. The sub-G1 peak represents the apoptotic degradation of genomic DNA. In concordance with these data survival curves of HeLa cells (Figure 1b) show that 1 and 5 ng/ml colcemid have no or only a transient influence on cell growth, which is overcome 24 h post-treatment. However, in the case of 10, 50 or 100 ng/ml colcemid the effect seems long lasting and results in massive apoptosis. Similarly, apoptosis-specific cleavage products of poly(ADPribose) polymerase 1 (PARP1) (Kaufmann et al., 1993) and htopoI (Casciola-Rosen et al., 1995; Samejima et al., 1999) could be determined after treatment with 100 ng/ml but not with 1 ng/ml colcemid (Figure 1c ). This verified the induction of a pronounced apoptotic response in HeLa cells to 100 ng/ml colcemid, whereas 1 ng/ml had a diminished effect. Finally, we investigated if htopoI cleavage complexes were detectable in response to treatment with colcemid. As shown in Figure 1c (bottom) a massive accumulation of htopoI cleavage complexes was observed 72 h after treatment with 100 ng/ml colcemid. A less pronounced, but still reproducible accumulation, of htopoI cleavage (b) Cell viability was determined using the alamarBlue assay. The curves show the mean value and the standard deviation (represented by error bars) of eight measurements using the indicated concentrations of colcemid. (c) For Western-blot analyses 70 mg protein from whole-cell lysates were separated by a 10% SDS-PAGE and blotted. HtopoI (C21; BD Biosciences Pharmingen, Heidelberg, Germany), PARP1 (Ab-2; Oncogene, Darmstadt, Germany) and b-actin (AC15; Sigma-Aldrich, Steinheim, Germany; as a loading control) were visualized using the indicated antibodies. The detection of htopoI cleavage complexes covalently attached to genomic DNA in response to colcemid treatment was performed by the ICT-assay as described in Materials and methods. DNA, 6 mg, was applied to each spot.
DNA damage-independent cleavage complex formation A Rockstroh et al complexes could be detected at 1 ng/mI colcemid as compared to the control. Thus, apoptosis induced by a non-DNA damaging agent involves the htopoI response. Accordant results were obtained with MCF7 cells (data not shown but also refer to Figure 4 ). To investigate whether cleavage complex formation correlated with the onset of apoptotic hallmarks, the time dependency of apoptosis induction was examined using 100 ng/ml colcemid. It was reported that in HeLa cells a terminal arrest at the mitotic checkpoint followed by apoptosis occurred approximately 24 h after continuous exposure to high concentrations (>20 ng/ml) of colcemid (Sherwood et al., 1994) . Our flow cytometry data were in agreement with these results (Figure 2a) . About 30 h after colcemid application a clear mitotic arrest combined with beginning apoptotic DNA fragmentation was visible. Cleavage of htopoI and PARP1 was observed around 50 h post-treatment ( Figure 2b) . Finally, an increasing number of htopoI cleavage complexes could be detected after 30-40 h of treatment ( Figure 2c ). Consequently, it seemed that the htopoI response was activated concomitantly with the appearance of apoptotic hallmarks (compare to Figure 2b and a). To get a better impression of the cleavage complex formation in time after colcemid treatment, we quantified four dot-blots and set the level of cleavage complexes reached at 72 h to 100% (Figure 2d ). Here, it is evident that the htopoI damage response slowly starts around 30 h where after the cleavage complex accumulation accelerates between 30 and 50 h and is close to a climax around 72 h (black squares). When compared with the survival curve (white squares) and the flow cytometry results (Figure 2a ) it is evident that the onset of the htopoI damage response correlates with the appearance of apoptotic hallmarks.
As shown in Figure 2 , a dramatic increase in the htopoI cleavage complex levels was observed after the treatment of HeLa cells with colcemid and that this correlated with cell death. In order to get an impression which impact so many cleavage complexes may have on the cell, we quantified the number of htopoI cleavage complexes attached to DNA. The signal intensities of the htopoI damage response to colcemid (Figure 3a , lower row) were directly compared to a htopoI standard ( Figure 3a , upper row). Based on the protein standard a calibration curve was generated ( Figure 3b ). This was used to calculate the number of htopoI molecules present on the dot-blot. Figure 3c shows that at the start of the htopoI damage response around eight htopoI cleavage complexes (40 h) exist for every Mbp DNA. This increases to around 31 and 87 htopoI cleavage complexes per Mbp DNA (50 and 72 h, respectively). This is a tremendously high number since one complex is enough to, for example, block transcription of a gene (Stewart et al., 1990) . Considering that each diploid cell has around 6.6 Â 10 9 bp DNA we estimate that 40, 50 and 72 h after addition of colcemid, one HeLa cell has about 5.2 Â 10 4 , 2.0 Â 10 5 and 5.8 Â 10 5 htopoI cleavage complexes, respectively. Previously, we have tested HeLa and MCF7 cells and found that both cell lines induce a htopoI damage response to UV-C irradiation (Soe et al., 2004) . In order to investigate whether the induction of the htopoI damage response by colcemid treatment is unique for (c) Using the ICT-assay, the kinetics of htopoI cleavage complex formation in response to 100 ng/ml colcemid was investigated. DNA, 6 mg, was applied to each spot. (d) The diagram shows a quantification of htopoI cleavage complex formation as shown in (c) (black squares) and the cell viability (white squares) plotted against time. The htopoI cleavage complex formation is represented as percent of the 72 h value. Cell viability was expressed as 'percent metabolic activity' as determined by the alamarBlue assay. Error bars represent the standard deviation of four quantified dotblots (htopoI cleavage complexes) and eight alamarBlue measurements (cell viability). Some measurement points may not show any error bar due to the size of the icon.
DNA damage-independent cleavage complex formation A Rockstroh et al HeLa cells or not, we treated MCF7 as well. Figure 4a clearly shows that colcemid blocks the cell cycle of MCF7 cells, but no DNA fragmentation can be observed as it was the case with HeLa cells (see Figures  1a and 2a) . This may be due to the fact that MCF7 cells have lost caspase 3 caused by a deletion within exon 3 of the CASP-3 gene (Janicke et al., 1998) . As fragmentation of genomic DNA by the DNA fragmentation factor-40 results primarily from the activity of caspase 3 (Wolf et al., 1999) no clear sub-G1 peak can be detected (Figure 4a ). Nevertheless, colcemid does cause cell death (Figure 4b ), but far less than it was the case with HeLa cells (compare Figures 1b and 4b ). Topoisomerase I is barely proteolytically cleaved despite of cell death (Figure 4c ). This is most likely because caspase 3 is the major caspase that cleaves htopoI during apoptosis (Samejima et al., 1999) . As caspase 3 is missing this does not take place. However, in the case of PARP1 it has been reported that other caspases also cleave PARP1 during apoptosis (Salvesen and Dixit, 1997; Huppertz et al., 1999) , which also explains why full-length PARP1 is almost completely digested even in the absence of caspase 3. The htopoI damage response to colcemid treatment in MCF7 cells starts around 50 h of treatment followed by a sudden increase at 72 h (Figure 4d ). The appearance of htopoI cleavage complexes is accompanied by a modest increase in p53 levels ( Figure 4c ). In contrast to HeLa cells it is evident that the htopoI damage response to colcemid treatment in MCF7 cells is a late event (Figure 4e ).
The fact that the htopoI damage response also is initiated by the microtubule inhibitor colcemid in two different cell lines, strongly indicates that not only DNA damaging agents are able to induce this response, but also cellular stress. To investigate this even further we chose to induce apoptosis through the TNFa receptor family. These types of receptors induce apoptosis (after binding of a ligand) by activating caspase 8 on the intracellular side of the cell membrane (Wajant et al., 2003) . In this way the caspase cascade is activated and apoptosis is initiated without a pre-existing DNA damage. Upon addition of TNFa we observed an apparent initial enhancement of cell growth within the first 24 h (Figure 5a ). However, after this initial positive effect an induction of cell death was observed which reached its maximum between a concentration of 40 and 100 ng/ml. The initial induction of cell growth may be explained by the fact that the TNFa receptor can induce cell growth as well as apoptosis depending on the cell type. In MCF7 cells it was described to result in apoptosis, which we also observe beyond 24 h. This massive cell death is accompanied by cleavage of PARP1 (Figure 5b) as well as the induction of the htopoI damage response (Figure 5c ). Before the 48 h time point we observed a very weak cleavage of PARP1 and induction of the htopoI damage response (data not shown) meaning that both responses started around the onset of apoptosis, but in the case of the htopoI damage response it culminated at 72 h.
Although the htopoI response was found to be involved in the apoptotic process following several treatments, only very little is known about the cellular pathways that contribute to cleavage complex formation. One study reported that p53 is an important regulator of the htopoI response following UV-C irradiation. This was shown by ectopical expression of p53 in a mutant p53 background (Mao et al., 2000) . Owing to the fact that this was performed in the presence of mutant p53 we wished to verify this result. Therefore, we repeated the experiment in a p53 (a) ) and comparing this to the protein standard within the same blot. In this way the number of htopoI cleavage complexes could be calculated. As 6 mg DNA was applied on each dot this could be converted to htopoI cleavage complexes per Mbp DNA.
DNA damage-independent cleavage complex formation
A Rockstroh et al background in the lung-carcinoma H1299-TOFF-p53 cell line (Chen et al., 1996) . Western-blot analyses showed ( Figure 6c ) the ectopical expression of p53 in the absence of doxycycline and a strongly reduced p53 level in the presence of doxycycline. The cells with high levels of p53 were found to be somewhat more sensitive to the UV-C irradiation than cells with strongly reduced levels of p53 (Figure 6a ). This difference in sensitivity cannot be ascribed to the effects of doxycycline itself, since its presence did not influence cell growth at all (Figure 6b) . Thus, the effect observed in Figure 6a can only be ascribed to the expression of p53. This slightly increased sensitivity to UV-C is correlated with the induction of a htopoI damage response in the presence of p53, but not in its absence. UV-C irradiation is not of physiological relevance, but introduces DNA lesions that are recognized by the cell and trigger apoptosis. Thus, using UV-C as a tool to induce apoptosis we could show that the htopoI damage response could be reconstituted in cells that were genetically deprived of the p53 gene, simply by reintroducing the expression of wt p53.
In agreement with these experiments, p53 expressing H1299-TOFF-p53 cells were clearly more sensitive to colcemid treatment than cells expressing very low, levels of p53 ( Figure 7a ). As it was the case with UV-C a clear dependence on p53 expression (Figure 7b ) was seen for the htopoI damage response to colcemid treatment as well (Figure 7c ).
Discussion
So far, it could be shown that htopoI cleavage complex formation arises in response to various DNA damaging treatments in cultured cells (Subramanian et al., 1998; Pommier et al., 2000; Pourquier et al., 2000 Pourquier et al., , 2001 Pourquier et al., , 2002 Daroui et al., 2004; Soe et al., 2004; Sordet et al., 2004a, b) . Previously, it was discussed that htopoI molecules could be trapped due to a direct recognition of the DNA damage, followed by cleavage of the DNA strand. Subsequent inhibition of the religation step was thought to be caused by a local distortion of the DNA double helix around the lesion. These assumptions were based on in vitro studies primarily using artificial DNA substrates containing a single lesion placed directly across from a preferential htopoI cleavage site (Lanza et al., 1996; Pourquier et al., 1997a Pourquier et al., , b, 1998 Pourquier et al., , 1999 Pommier et al., 2000 Pommier et al., , 2002 . However, this has never been shown to be the case in vivo. As colcemid and TNFa trigger apoptosis independent of DNA damage, this indicates, that a pre-existing DNA lesion is not necessarily required for the htopoI response. We suggest that signaling pathways independent of the kind of cellular stress may cause cleavage complex formation. Accordingly, these stress signals can arise from either DNA damage or DNA damage-independent stimuli-like activation of cell cycle checkpoints or death receptor binding. In addition, published data also suggest that DNA damage-independent cleavage complex formation A Rockstroh et al htopoI cleavage complex formation in response to DNA damage is incorporated into a cellular signaling pathway. The group of Muller et al. could show that cell lines deficient in different factors of the NER pathway possess a diminished or nearly absent htopoI response despite of receiving an equal quantity of UV irradiation (Subramanian et al., 1998) . The same could be shown in the absence of wt p53 following UV irradiation (Mao et al., 2000 and present data) . This demonstrates that even if the level of DNA damage is comparable, the resulting htopoI response can differ if protein factors are missing, suggesting a model in which htopoI is recruited to DNA by cellular signaling. Therefore, we suggest that protein interactions or signaling cascades induced by DNA damage or cellular stress are the main players that trigger the formation of stabilized cleavage complexes rather than the DNA lesion by itself.
Nevertheless, it cannot be ruled out, that reactive oxygen species (ROS), generated by mitochondria throughout the apoptotic process, may cause secondary DNA damage, since oxidative DNA lesions are known to induce cleavage complex formation (Sordet et al., 2004b) . We attempted to address this question by trying to scavenge ROS using the antioxidant N-acetylcysteine (Aruoma et al., 1989) . Cotreatment of cells with colcemid and N-acetylcysteine, however, led to an unaffected or even elevated level of cleavage complexes compared to colcemid treatment alone (data not shown). Moreover, we have shown that the htopoI response is strongly dependent on the p53 status in the H1299-TOFF-p53 cell line (Figures 6 and 7) . p53-negative cells undergoing cell death were not found to accumulate htopoI cleavage complexes despite the fact that they also should generate ROS during the apoptotic Figure 5 HtopoI cleavage complex formation in MCF7 cells after treatment with TNFa. (a) The sensitivity of MCF7 cells to treatment with TNFa was determined using the alamarBlue assay. Error bars represent the standard deviation of four measurements. (b) Cells were cultured with 100 ng/ml TNFa and harvested at different time points after drug application. For Western-blot analysis extracts from 100 000 cells were separated by a 10% SDS-PAGE, blotted and visualized as indicated in Figure 1c . (c) Detection of htopoI cleavage complex formation in response to 100 ng/ml TNFa treatment according to the ICT-assay. DNA, 12 mg, was applied to each dot. Figure 6 The htopoI damage response to UV-C irradiation depends on the presence of p53. H1299-TOFF-p53 cells were grown with (repression of p53) or without (expression of p53) 2 mg/ ml doxycycline supplemented to the culture medium. Irradiation with 50 J/m 2 UV-C light was performed as described in Materials and methods. Control cells [C] were cultured under the same conditions but without irradiation. (a) Sensitivity of H1299-TOFFp53 cells (7doxycycline) to UV-C irradiation was determined according to the alamarBlue assay. Error bars represent the standard deviation of four measurements. (b) Influence of doxycycline on the cell growth of H1299-TOFF-p53 cells without treatment determined by the alamarBlue assay. Error bars represent the standard deviation of four measurements. Some measurement points may not show any error bar due to the size of the icon. (c) Western blot of the p53 expression levels in the presence and absence of doxycycline. The Western blot was performed with whole-cell extracts from 100 000 cells after irradiation with 50 J/m 2 UV-C light, using the DO-1 monoclonal antibody against p53. Additionally, b-actin was visualized as a loading control. (d) Dot-blot showing the htopoI cleavage complex formation in the presence or absence of p53 in response to UV-C irradiation (as in c). DNA, 6 mg, was applied to each dot.
process. Therefore, it is unlikely that secondary DNA lesions caused by ROS were the major cause of the strong htopoI response observed after colcemid and TNFa treatment.
These findings further indicate that p53 is an important factor in the signaling pathway leading to the htopoI response. It might be suggested that initial htopoI cleavage complex formation is caused by stress signals involving p53 as a mediator protein, independent of the stimulus of cellular stress. This conclusion is consistent with a model proposed by Mao et al. (2000) in which htopoI cleavage complexes may assist in forcing p53-dependent cell cycle checkpoints to eliminate cells by apoptosis that are destined to be precancerous. In addition, at later stages of the apoptotic process, the release of ROS might lead to oxidative DNA damage, which in turn may facilitate further cleavage complex formation.
MCF7 cells displayed a diminished and delayed htopoI response compared to HeLa cells. This is particularly clear when Figures 2d and 4e are compared. HeLa cells clearly have a gradually increasing cleavage complex formation that coincides with a reduction in cell survival. In contrast, MCF7 cells showed a very delayed htopoI damage response although the effects on cell survival were detected earlier. One thing that is evident is that HeLa cells were much more sensitive to colcemid treatment than MCF7 cells (compare Figures  1b and 4b ). This does, however, not explain why the MCF7 cells that do die, show such a delayed response. One possible reason may be the lack of caspase 3. Recent work has shown that caspase 3 is important but not essential for the induction of the htopoI damage response (Sordet et al., 2004b) . This group found that an inhibition of caspase 3 activity merely resulted in a delayed and more sudden response, very much like our observations in MCF7 cells. It is therefore possible that caspase 3 deficiency at least in part is responsible for the delayed htopoI damage response in MCF7 cells.
Moreover, it is still unclear what the role of the htopoI response during cell death is. It was suggested that htopoI cleavage complexes actively participate in the apoptotic fragmentation of the genome (Sordet et al., 2004a, b) . To get an impression on the plausibility of this suggestion, we estimated the number of htopoI cleavage complexes induced per Mbp DNA after apoptosis-inducing treatments. We found that on average around 87 htopoI cleavage complexes were formed per Mbp DNA in HeLa cells after 72 h of colcemid treatment. This means, one htopoI cleavage complex, and therefore one resulting single strand break, would be placed every 11 500 deoxynucleotides on double-stranded DNA at a late stage of apoptosis. Owing to this large number it could be speculated that htopoI may be involved in the high molecular weight DNA-fragmentation process during apoptosis. Nevertheless, the single strand breaks caused by the cleavage complexes have to be converted into double-strand breaks to result in DNA fragmentation. This requires DNA replication or other yet unknown mechanisms. Alternatively, cleavage complexes may also serve as a 'roadblock' for transcription and replication and thereby completely stop new synthesis of protein or attempted cell growth. However, further investigations are required to highlight this issue.
However, it is clear that htopoI does not play an essential role during apoptosis since Figures 6 and 7 show that cells, which undergo apoptosis in the absence of p53 do not induce the htopoI damage response. However, it may very well be a contributing factor since the presence of the response is correlated with increased sensitivity. The observation that TNFa also triggers the htopoI damage response strongly supports that this response is physiologically relevant. TNFa is a naturally occurring cytokine secreted by cells of the immune system triggering apoptosis in some tumor cells while leaving healthy tissue mostly unaffected (Wajant et al., 2003) . As we show that the htopoI damage response is part of the TNFa response and apoptosis in general, it is likely that it is also an important player under physiological conditions within the human body. Figure 7 The htopoI damage response to colcemid treatment is regulated by p53. H1299-TOFF-p53 cells were grown in the presence or absence of 2 mg/ml doxycycline to down-or upregulate p53-expression, respectively. Treatments were carried out with 100 ng/ml colcemid. Control cells [C] were cultured under the same conditions without drug application. (a) Sensitivity of H1299-TOFF-p53 cells to colcemid treatment, with up-or downregulated p53 expression levels, was determined using the alamarBlue assay. Error bars represent the standard deviation of four measurements. (b) Western blot of the p53 expression levels in the presence and absence of doxycycline. The Western blot was performed as described in Figure 6c . (c) Dot-blot showing the htopoI cleavage complex formation in the presence or absence of p53 in response to 100 ng/ml colcemid treatment. DNA, 6 mg, was applied to each dot.
Furthermore, the fact that numerous chemotherapeutic drugs seem to kill tumor cells, for example by inducing htopoI cleavage complexes (Pourquier et al., , 2002 Sordet et al., 2004b) , makes the htopoI damage response a highly relevant and important pathway to analyse in further detail, since the so obtained knowledge may help to improve or understand the action of chemotherapeutics.
Materials and methods

Cell culture
All cell lines were cultured at 371C and appropriate humidity. HeLa S3 cells (cervix carcinoma; ATCC, Wesel, Germany) were grown at 10% CO 2 in Dulbecco's modified Eagle's medium MCF7 (mamma carcinoma; ATCC, Wesel, Germany) cells at 5% CO 2 in Rosewell's Park Memorial Institute (RPMI) medium (C-C-pro GmbH, Neustadt/Weinstrasse, Germany), each supplemented with 10% fetal calf serum (FCS; Gibco, Karlsruhe, Germany). H1299-TOFF-p53 cells (lung carcinoma; kindly provided by Dr Carol Prives, Columbia University, NY, USA) were cultured at 5% CO 2 in RPMI medium supplemented with 2 mg/ml puromycin (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) and 300 mg/ml G418 (Calbiochem, Darmstadt, Germany) besides 10% FCS. To downregulate the ectopical expression of p53, the cells were cultivated in the presence of 2 mg/ml doxycycline (Sigma-Aldrich Chemie GmbH, Steinheim, Germany). p53 expression was induced by the removal of doxycycline 4 days before an experiment.
Treatments
Colcemid (Fluka, Buchs SG, Switzerland) and TNFa (human recombinant protein; Biomol GmbH, Hamburg, Germany) were dissolved in dimethylsulphoxide (DMSO) and H 2 O, respectively, and were directly applied to the cell culture. Control cells were treated with the appropriate amounts of solvent. During irradiation (UV-Stratalinker 1800; Stratagene, La Jolla, CA, USA) at 254 nm (UV-C, B25 J/m 2 s) the cells were kept wet by a thin layer of phosphate-buffered saline (PBS). Afterwards, fresh medium was added and the culture dish was returned to the incubator for the indicated times. Control cells were treated with PBS but were not irradiated.
ICT-assay
The ICT-assay was performed as described previously (Subramanian et al., 1998; Soe et al., 2004) . To show that the ICT-assay is suited for the detection of htopoI covalently attached to genomic DNA the proper controls are included in Supplementary Information Figures S1, S2 and S3.
Western blotting Cells were lyzed in 1% N-lauroylsarcosine (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) and the resulting wholecell extracts were sonified (Branson Ultrasonic SA, France). Protein concentrations were determined according to Bradford (1976) . The indicated amounts of total protein were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and afterwards blotted as described (Soe et al., 2004) or a fixed amount of cells was directly lyzed in gel loading-buffer and applied to SDS-PAGE.
Flow cytometry
Harvested cells were fixed in absolute ethanol and stored at 41C. Before analysis, fixed cells were washed in PBS and subsequently incubated in PBS containing 250 mg/ml RNAse A (Quiagen GmbH, Hilden, Germany) and 40 mg/ml propidium iodide (Fluka, Buchs SG, Switzerland) for 30 min at 371C in the dark. Analyses were carried out with a Beckman-Coulter EPICS XL-MCL flow cytometer (Beckman-Coulter, Krefeld, Germany) measuring approximately 10 000 cells.
The alamarBlue assay
The alamarBlue (BioSource Europe, Nivelles, Belgium) is a nontoxic dye that can be used to assess cell viability and proliferation by monitoring the reducing environment of proliferating cells. The alamarBlue assay was performed according to the manufacturer's protocol. In short, 1 day before treatment, a definite cell number was seeded out in 96-well plates. Directly after treatment, 10% (v/v) alamarBlue was added to each well. A well without cells but containing culture medium and alamarBlue was used as negative control. Upon proliferation, alamarBlue changes from its oxidized to the reduced form. The resulting shift in color was successively measured by absorbance at 570 and 600 nm (SpectraMax 250; Molecular Devices GmbH, Ismaning, Germany), starting approximately 1 day after treatment. Only in the case of TNFa, alamarBlue was supplemented 6 h before each measurement, since we found that the dye influences the activity of the drug. For the depiction of cell proliferation, data were expressed as 'percent reduced alamarBlue'. Viability of treated cells was determined by 'percent metabolic activity' of the untreated control. Thereby the 'percentage of reduced alamarBlue' of the control was defined as 100% metabolic activity.
Quantification of htopoI cleavage complexes
Intensities of dot-blot signals were quantified using the Kodak 1D Image Analysis Software (Eastman Kodak Company, New Haven CT, USA). Data derived from defined amounts of purified, recombinant htopoI applied onto a dot-blot were used to generate a calibration curve. Based on this calibration curve, the measured signal intensities derived from treated cells could be correlated to the amount of htopoI protein. As the applied amount of DNA was also known, the number of htopoI cleavage complexes per Mbp was estimated.
